RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
1507. Saunders RN, Metcalfe MS and Nicholson ML. Rapamycin in
transplantation: a review of the evidence. Kidney Int 59: 3-
16, 2001.
1508. Legendre C, Campistol JM, Squifflet JP Burke JT; Sirolimus
European Renal Transplant Study Group. Cardiovascular risk
factors of sirolimus compared with cyclosporine: early experience
from two randomized trials in renal transplantation.
Transplant Proc 35 (Suppl 3A): S151-S153, 2003.
1509. Oberbauer R, Kreis H, Johnson RWG, Mota A, Claesson K,
Ruiz JC y cols. Long-term improvement in renal function
with sirolimus after early cyclosporine withdrawal in renal
transplant recipients: 2-year results of the rapamune maintenance
study. Transplantation 76: 364-70, 2003.
1510. Pham SM, Shears LL, Kawaharada N, Li S, Venkataramanan
R, Sehgal S. High local production of nitric oxide as a possible
mechanism by which rapamycin prevents transplant
arteriosclerosis. Transplant Proc 30: 953-4, 1998.
1511. Sousa JE, Costa MA, Abizaid A, Abizaid AS, Feres F, Pinto IM
y cols. Lack of neointimal proliferation after implantation of
sirolimus-coated stents in human coronary arteries: a quantitative
coronary angiography and three-dimensional intravascular
ultrasound study. Circulation 103: 192-5, 2001.
1512. Roodnat JI, Mulder PGH, Rischen-Vos J, Van Riemsdijk IC,
van Gelder T, Zietse R y cols. Proteinuria and death risk in
renal transplant population. Transplant Proc 33: 1170, 2001.
1513. Peddi VR, Dean De, Hariharan S, Cavallo T, Schroeder TJ,
First MR.Proteinuria following renal transplantation: correlation
with histopathology and outcome. Transplant Proc 29:
101, 1997.
1514. Altiparmak MR, Trablus S, Apaydin S, Basar O, Sariyar M,
Serdengecti K y cols. Is losartan as effective as enalapril on
posttransplant persistent proteinuria? Transplant Proc 33:
3368-9, 2001.
1515. Ersoy A, Dilek K, Usta M, Yavuz M, Gullulu M, Oktay B y
cols. Angiotensin-II receptor antagonist losartan reduces
microalbuminuria in hypertensive renal transplant recipients.
Clin Transplant 16: 202-5, 2002.
1516. Suwelack B, Kempkes-Koch M, Kobelt V, Hillebrand U,
Matzkies F, Gerhardt U y cols. Impact of ACE polymorphism
on renal allograft function, blood pressure and proteinuria
under ACE inhibition. Transplant Proc 34: 1763-6, 2002.
1517. Fernández-Fresnedo G, Palomar R, Escallada R, Cotorruelo
JG, Zubimendi JA, Sanz de Castro S y cols. Hypertension and
long-term renal allograft survival: effect of early glomerular
filtration rate. Nephrol Dial Transplant 16 (Suppl 1): 105-9,
2001.
1518. First MR. Long-term complications after transplantation. Am
J Kidney Dis 22: 477-86, 1993.
1519. Painter PL; Hector L, Ray K, Lynes L, Paul SM, Dodd M y cols.
Effects of exercise training on coronary heart disease risk factors
in renal transplant recipients. Transplantation 42: 362-9,
2003.
1520. Midtvedt K, Ihlen H, Hartmann A, Bryde P, Bjerkely BL, Foss
A y cols. reduction of left ventricular mass by lisinopril and
nifedipine in hypertensive renal transplant recipients: a prospective
randomized doule-blind study. Transplantation 72:
107-11, 2001.
1521. Hernández D, Lacalzada J, Salido E, Linares J, Barragan A,
Lorenzo V y cols. Regression of left ventricular hypertrophy
by lisinopril after renal transplantation: role of ACE gene
polymorphism. Kidney Int 58: 889-97, 2000.
1522. Fishel RS, Eisenberg S, Shai S-Y, Redden RA, Bernstein KE,
Berk BC.Glucocorticoids induce angiotensin-converting
enzyme expression in vascular smooth muscle.
Hypertension 25: 343-9, 1995.
1523. Zhu J, Shearer GM, Norman JE, Pinto LA, Marincola FM,
Prasad A y cols. Host response to cytomegalovirus infection
as a determinant of susceptibility to coronary artery disease:
sex-based differences in inflammation and type of immune
response. Circulation 102: 2491-6, 2000.
1524. Potena L, Grigioni F, Ortolani P, Magnani G, Marrozzini C,
Falchetti E y cols. Relevance of cytomegalovirus infection
and coronary-artery remodelling in the first year after heart
transplantation: a prospective three-dimensional intravascular
ultrasound study. Transplantation 75: 839-43, 2003.
1525. Lemström K, Koskinen P and Häyry P. Molecular mechanisms
of chronic allograft rejection. Kidney Int 48 (Suppl 52):
S2-10, 1995.
1526. Akposso K, Rondeau E, Haymann JP, Peraldi MN, Marlin C
and Sraer JD. Long-term prognosis of renal transplantation
after preemptive treatment of cytomegalovirus infection.
Transplantation 63: 974-6, 1997.
1527. Krogerus L, Soots A, Bruggeman C, Loginov R, Ahonen J and
Lautenschlager I. CMV increases TNF-_ expression in a rat
kidney model of chronic rejection. Transplant Proc 35: 803,
2003.
1528. Jacobs U, Brensing KA and Klehr HU. Chronic allograft destruction
vs chronic allograft rejection. Transplant Proc 26:
3119-20,1994.
1529. Kasiske BL. Immune and nonimmune clinical correlates of
chronic renal allograft rejection. Transplant Proc 29:
2557,1997.
1530. Frei U, Schindler R, Wieters D, Grouven U, Brunkhorst and
Koch M. Pre-transplant hypertension: a major risk factor for
chronic progressive renal allograft dysfunction? Nephrol
Dial Transplant 10: 1206-11, 1995.
1531. Ritz E, Schwenger V, Wiesel M and Zeier M. Atherosclerotic
complications after renal transplantation. Transpl Int 13
(suppl 1): S14-S19, 2000.
1532. Rodrigo E, González-Lamuño D, Ruiz JC, Fernandez-
Fresnedo G, Isla D, Gonzalez-Cotorruelo J y cols.
Apolipoprotein C-III and E polymorphisms and cardiovascular
syndrome, hyperlipidemia, and insulin resistance in renal
transplantation. Am J Transplant 2: 343-8, 2002.
1533. Herzog CA. Dismal long-term survival of dialysis patients
after acute myocardial infarction: can we alter the outcome?
Nephrol Dial Transplant 17:7-10, 2002.
1534. Humar A, Kerr SR, Ramcharan T, Gillingham KJ, Matas AJ.
Peri-operative cardiac morbidity in kidney transplant recipients:
incidence and risk factors. Clin Transplantation 15:
154-8, 2001.
1535. Oliveras A, Roquer J, Puig JM, Rodriguez A, Mir M, Orfila
MA y cols. Stroke in renal transplant recipients: epidemiology,
predictive risk factors and outcome. Clin Transplant
17:1-8, 2003.
1536. Moe SM, O’Neill KD, Resterova M, Fineberg N, Persohn S,
Meyer CA. Natural history of vascular calcification in dialysis
and transplant patients. Nephrol Dial Transplant 19:2387-
93; 2004
1537. Sung RS, Althoen M, Howell TA, Merion RM. Peripheral vascular
occlusive disease in renal transplant recipients: risk
factors and impact on kidney allograft survival.
Transplantation 70:1049-54,2000.
233